tomeko

Autosomal recessive hyperinsulinism due to SUR1 deficiency

Just diagnosed with Autosomal recessive hyperinsulinism due to SUR1 deficiency?

You are not alone. Here is where to start: learn the basics, find a specialist or center that sees Autosomal recessive hyperinsulinism due to SUR1 deficiency, look for clinical trials, and connect with others living with it — all in one place.

Open the full Autosomal recessive hyperinsulinism due to SUR1 deficiency hub →

Overview

Autosomal recessive hyperinsulinism due to SUR1 deficiency is a rare condition. Also known as Autosomal recessive hyperinsulinemic hypoglycemia due to SUR1 deficiency. Tomeko brings together the specialists, research, clinical trials, treatments and community for Autosomal recessive hyperinsulinism due to SUR1 deficiency so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.

Identifiers: ORPHA:79643 · OMIM 256450 · ICD-10 E16.1 · GARD 0016726

Find care for Autosomal recessive hyperinsulinism due to SUR1 deficiency

Authoritative references for Autosomal recessive hyperinsulinism due to SUR1 deficiency

Common questions

I was just diagnosed with Autosomal recessive hyperinsulinism due to SUR1 deficiency — what should I do first?

Start by learning the basics from an authoritative source, find a specialist or center that sees Autosomal recessive hyperinsulinism due to SUR1 deficiency, and connect with a patient organization. Tomeko brings these together on one hub.

Where can I find a specialist for Autosomal recessive hyperinsulinism due to SUR1 deficiency?

Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat Autosomal recessive hyperinsulinism due to SUR1 deficiency, filtered to your area.

Are there clinical trials for Autosomal recessive hyperinsulinism due to SUR1 deficiency?

Tomeko shows live, recruiting studies for Autosomal recessive hyperinsulinism due to SUR1 deficiency from ClinicalTrials.gov on the hub.

Informational only — not medical advice. Always consult a qualified clinician. Provider and reference data from public sources (NIH GARD, Orphanet, OMIM, HPO, MONDO, ClinicalTrials.gov, CMS NPPES). © Tomeko · tomekohealth.com